The National Institutes of Health (NIH), located in Bethesda, MD is the nation’s medical research agency. The Human Eosinophil Section is a division within NIH’s National Institute of Allergy and Infectious Diseases. The team conducts basic and translational research related to the role of eosinophils and eosinophil activation in disease processes. The ultimate goal of the team is to develop diagnostic tools and treatments for eosinophilic conditions, including eosinophilic gastrointestinal disorders (EGID).
Many of the protocols at the NIH are being conducted to investigate novel therapies to treat EGID as well as working to develop better methods to study patient reported outcomes. The investigators take a multidisciplinary approach in understanding EGID and treating patients. The team works closely with gastroenterologists, allergists, nutritionists and others. The investigators at the National Institutes of Health are a participating center of CEGIR.
Current ongoing research protocols